Bar-Zeev, Yael http://orcid.org/0000-0002-1916-836X
Skelton, Eliza
Bonevski, Billie
Gruppetta, Maree
Gould, Gillian S.
Funding for this research was provided by:
Hunter Cancer Research Alliance (Not applicable)
Cancer Institute NSW (15ECF/I-52)
National Health and Medical Research Council (APP1092085)
Article History
Received: 21 November 2018
Accepted: 29 January 2019
First Online: 7 February 2019
Ethics approval and consent to participate
: This study was approved by the University of Newcastle Human Research Ethics Committee (H-2016-0063, 08/06/2016). Verbal consent from the participants was obtained and recorded at the beginning of the phone interview. The ethics committee formally approved this consent process.
: Not applicable.
: YBZ has received funds in the past (2012–2015) from Novartis NCH who used to distribute NRT in Israel. She has not received any funding from pharmaceutical companies in Australia. All other authors declare no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.